STOCK TITAN

USA COMPRESSION PTNRS LP Form 4 Filings

USAC OTC

Every Form 4 that USA COMPRESSION PTNRS LP (USAC) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.

A Form 4 covers the transactions officers, directors and large holders report, so if you follow USAC and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full USAC filings page.

Rhea-AI Summary

USA Compression Partners, LP (USAC) director Bradford D. Whitehurst reported open-market purchases of the issuer’s common units. On August 20, 2026 he purchased 4,000 Common Units at $26.40 per unit, and on August 21, 2026 he purchased an additional 6,000 Common Units at $26.10 per unit. A related footnote states that his common unit holdings include units acquired under the issuer’s Distribution Reinvestment Plan.

Rhea-AI Summary

Porter Christopher W reported acquisition or exercise transactions in this Form 4 filing.

USA Compression Partners, LP reported that executive Christopher W. Porter received an award of 20,000 Common Units as a compensation grant, not an open-market purchase. These are Restricted Units that vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on his continued employment. Following this award, Porter holds a total of 128,001 Common Units directly.

Rhea-AI Summary

Holotik Jim reported acquisition or exercise transactions in this Form 4 filing.

USA Compression Partners, LP director Jim Holotik received an equity award of 2,500 phantom units as compensation. These units are tied to the company’s common units representing limited partner interests rather than being bought on the open market.

According to the award terms, 60% of the phantom units will vest on December 5, 2028 and the remaining 40% will vest on December 5, 2030. Each phantom unit represents the right to receive one common unit after it vests, and Holotik is reported as directly owning 2,500 units following this grant.

Rhea-AI Summary

USA Compression Partners, LP officer Christopher W. Porter reported an open-market sale of 40,000 common units. The weighted average sale price was $26.64 per unit, with individual trades executed between $26.45 and $27.00. After these transactions, Porter directly owns 108,001 common units.

Rhea-AI Summary

USA Compression Partners, LP director buys additional units. Director Bradford D. Whitehurst purchased 10,000 Common Units of USA Compression Partners, LP in an open-market transaction at a price of $26.75 per unit. Following this purchase, he directly owns 33,616 Common Units, including units acquired under the Distribution Reinvestment Plan.

Rhea-AI Summary

USA Compression Partners, LP reported an equity award to a director-level insider. On January 2, 2026, the reporting person acquired 4,338 common units of USA Compression Partners, LP at a price of $0, increasing their beneficial ownership to 11,332 common units, held directly.

The new units are described as an award of Restricted Units granted under the USA Compression Partners, LP Long-Term Incentive Plan. These units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the reporting person’s continued employment with USA Compression Partners, LP or one of its affiliates through each vesting date. The reporting person serves as a director of USA Compression GP, LLC, the general partner that manages the partnership.

Rhea-AI Summary

USA Compression Partners, LP insider equity grant reported

A director of USA Compression Partners, LP reported receiving an award of 4,338 common units on January 2, 2026. The filing shows these units were acquired at a stated price of $0, indicating they are a form of equity compensation rather than an open‑market purchase. Following this grant, the reporting person beneficially owns 53,453 common units directly.

The 4,338 units are structured as restricted units under the USA Compression Partners, LP Long-Term Incentive Plan. They are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the director’s continued service with the partnership or its affiliates through each vesting date.

Rhea-AI Summary

USA Compression Partners, LP reported an insider equity grant to one of its directors. On 01/02/2026, the director acquired 4,338 common units of USA Compression Partners, LP at a stated price of $0, increasing the director’s beneficial ownership to 53,453 common units, held directly.

The transaction represents an award of restricted units under the USA Compression Partners, LP Long-Term Incentive Plan. These restricted units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the director’s continued employment with the partnership or one of its affiliates on each vesting date. The reporting person serves as a director of USA Compression GP, LLC, the general partner that manages the issuer.

Rhea-AI Summary

USA Compression Partners, LP reported an equity award to one of its directors. On 01/02/2026, the reporting person received 4,338 common units of USA Compression Partners, LP at a price of $0, increasing their beneficial ownership to 11,332 units held directly.

The award consists of restricted units granted under the USA Compression Partners, LP Long-Term Incentive Plan. These units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on the director’s continued employment with USA Compression Partners, LP or its affiliates on each vesting date. The reporting person serves as a director of USA Compression GP, LLC, the general partner that manages USA Compression Partners, LP.

Rhea-AI Summary

USA Compression Partners, LP reported insider equity transactions by an officer on 12/19/2025. The reporting person, who is Vice President and Controller of the general partner, settled vested phantom units, which are each economically equivalent to one common unit, partly in cash and partly in common units.

On that date, phantom units converted into 3,215 common units and separately into another 4,083 common units, while 1,608 common units and 2,042 common units were sold at $24.27 per unit. After these transactions, the officer directly owned 40,928 common units and held 2,721 phantom units as derivative securities, subject to vesting and forfeiture terms tied to continued service.

Rhea-AI Summary

USA Compression Partners, LP insider activity: A senior officer reported multiple transactions in common units and related phantom units on 12/19/2025. The officer acquired 18,568 and 24,458 common units through the settlement of phantom units and sold 9,284 and 12,229 common units at a price of $24.27 per unit. After these transactions, the officer directly held 148,001 common units.

The filing also shows phantom units that were originally granted on December 5, 2020 and December 5, 2022. One grant vested in full on December 5, 2025, while another vests 60% on December 5, 2025 and 40% on December 5, 2027. Each phantom unit is economically equivalent to one common unit, and any unvested phantom units are forfeited if the officer’s service ends.

Rhea-AI Summary

USA Compression Partners insider activity: A senior officer of USA Compression Partners, LP reported transactions in common units tied to vesting of phantom units on 12/19/2025. The officer acquired 8,038 common units and 13,065 common units through the settlement of phantom units, then disposed of 4,019 units and 6,533 units at a price of $24.27 per unit. Following these transactions, the officer directly beneficially owned 89,711 common units.

Each phantom unit is economically equivalent to one common unit. A 2020 phantom unit grant vested in full on 12/5/2025, and a 2022 grant vests 60% on 12/5/2025 and 40% on 12/5/2027. Unvested phantom units are forfeited if the officer’s service ends.

Rhea-AI Summary

USA Compression Partners, LP reported an equity compensation grant to an officer. On December 5, 2025, a vice president and controller of the general partner received 11,250 common units as restricted units at a stated price of $0, increasing their directly held units to 37,280 after the transaction. These restricted units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, contingent on continued employment.

The officer also received 3,750 cash units under a long-term cash restricted unit plan, with one-third vesting on each of December 5, 2026, December 5, 2027, and December 5, 2028, again subject to continued employment. These cash units, which correspond to common units for valuation purposes, will be settled solely in cash based on the average closing price of the common units over the ten trading days preceding each vesting date, and contributed to total derivative securities beneficially owned of 5,437.

Rhea-AI Summary

USA Compression Partners, LP granted equity and cash-based awards to a senior officer on December 5, 2025. The officer received 34,575 restricted common units at a price of $0, increasing direct beneficial ownership to 79,160 common units. These restricted units vest 60% on December 5, 2028 and 40% on December 5, 2030, contingent on continued employment.

The officer was also granted 11,525 cash units under the long-term cash restricted unit plan, with one-third scheduled to vest on each of December 5, 2026, 2027, and 2028, subject to continued employment. These cash units will be settled solely in cash based on the fair market value of the issuer’s common units at each vesting date, and 14,895 derivative securities are reported as beneficially owned following the transactions.

Rhea-AI Summary

USA Compression Partners, LP reported new equity and cash-based awards to a senior executive. On December 5, 2025, the executive received 36,600 common units as an award of restricted units at a price of $0, increasing their directly held beneficial ownership to 92,850 common units. These restricted units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally requiring continued employment through each vesting date.

The executive was also granted 12,200 cash units under the Long-Term Cash Restricted Unit Plan. These cash units are scheduled to vest in three equal installments on December 5, 2026, December 5, 2027, and December 5, 2028, and will be settled solely in cash based on the average closing price of the issuer’s common units over the ten trading days before each vesting date.

Rhea-AI Summary

USA Compression Partners, LP reported an equity and cash-based compensation grant to a senior executive. On December 5, 2025, the officer received 102,525 common units at a price of $0, increasing beneficial ownership to 186,795 common units held directly. These restricted units vest 60% on December 5, 2028 and 40% on December 5, 2030, generally contingent on continued employment. The executive also received 34,175 cash units under a long‑term cash plan, scheduled to vest in three equal installments on December 5, 2026, December 5, 2027, and December 5, 2028. These cash units are settled solely in cash based on the average closing price of the underlying common units over the ten trading days before each vesting date, and the executive now beneficially owns 52,902 derivative securities directly.

Rhea-AI Summary

USA Compression Partners, LP reported an equity award to a senior executive. On December 5, 2025, the Vice President, General Counsel and Secretary of USA Compression GP, LLC, the general partner of USA Compression Partners, received 35,400 restricted common units under the USA Compression Partners, LP Long-Term Incentive Plan. These units are scheduled to vest 60% on December 5, 2028 and 40% on December 5, 2030, generally requiring continued employment through each vesting date.

The executive also received an award of 11,800 cash units under the USA Compression Partners, LP Long-Term Cash Restricted Unit Plan. These cash units are scheduled to vest in three equal installments on December 5, 2026, December 5, 2027, and December 5, 2028, with payment in cash based on the average closing price of USA Compression’s common units during the ten trading days before each vesting date.